Clinical trial / 2020
A 3-month pilot study of a watermelon-enhanced anti-inflammatory diet found no group-by-time interactions for body habitus, inflammatory, or metabolic markers.
A 3-month self-selection pilot study evaluated a watermelon-focused Inflammation Management Intervention (n = 15) versus basic health education controls (n = 8). There were no group-by-time interactions for any studied outcomes. Post hoc analyses grouped participants by change in energy-adjusted Dietary Inflammatory Index (E-DII) score, noting that some intervention participants became more proinflammatory and several controls became more anti-inflammatory. Those with more anti-inflammatory dietary changes (below median E-DII change) showed differences in body fat percent (-1.27% vs +0.90%, P = .01), BMI (-0.66 vs +0.38 kg/m2, P = .06), and body weight (-0.99 vs +0.54 kg, P = .08).
- Study type
- 3-month self-selection pilot trial
- Who was studied
- 23 participants (15 intervention, 8 control)
- What was measured
- Body habitus, markers of inflammation, and metabolism
THE PAPER
Impact of a 3-Month Anti-inflammatory Dietary Intervention Focusing on Watermelon on Body Habitus, Inflammation, and Metabolic Markers: A Pilot Study.
Wirth MD, Shivappa N, Khan S, Vyas S, Beresford L, Sofge J, Hébert JR. Nutr Metab Insights, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.